Oral hypoglycaemic agents

  • D. R. Hadden


Metformin Tolbutamide Coeliac Disease IRISH Journal Chlorpropamide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Boyle, D., Bhatia, S. K., Hadden, D. R., Montgomery, D. A. D. and Weaver, J. A. 1972. Ischaemic heart disease in diabetics—a prospective study. Lancet i, 338.CrossRefGoogle Scholar
  2. Bloom, A. 1972. Oral therapy in diabetes. J. Roy. Coll. Physns. London, 7, 61.Google Scholar
  3. Chu, P., Conway, M. J., Krause, H. A. and Goodner, C. J. 1968. The pattern of response of plasma insulin and glucose to meals and fasting during chlorpropamide therapy. Ann. Int. Med. 68, 757.PubMedGoogle Scholar
  4. Creutzfeldt, W., Willms, B. and Caspary, W. 1971. The mechanism of action of the blood glucose lowering biguanides. Diabetes: Proceedings of the Seventh Congress of the International Diabetes Federation. 708. Excerpta Medica, Amsterdam 1971.Google Scholar
  5. Emerson, Ralph Waldo. 1803 – 1882. From the hymn sung at the completion of the Concord Monument.Google Scholar
  6. Hadden, D. R., Montgomery, D. A. D. and Weaver, J. A. 1972. Myocardial infarction in maturity onset diabetics. Lancet i, 335.CrossRefGoogle Scholar
  7. Hadden, D. R., Boyle, D., Montgomery, D. A. D. and Weaver, J. A. 1973. Risk factors for myocardial infarction in maturity onset diabetes. The Practitioner (in press).Google Scholar
  8. Keen, H. 1970. Minimal diabetes and arterial disease, prevalence and the effect of treatment in early diabetes. New York Academic Press, 437.Google Scholar
  9. Paasikivi, J. and Wahlberg, F. 1971. Preventive tolbutamide treatment and arterial disease in mild hyperglycaemia. Diabetologia 7, 323.PubMedCrossRefGoogle Scholar
  10. Prout, T. E. 1971. A protective view of the treatment of adult onset diabetes. Med. Clin. N. America, 55, 1065.PubMedGoogle Scholar
  11. Rigas, A. N., Bittles, A. H., Hadden, D. R. and Montgomery, D. A. D. 1968. Circadian variation of glucose, insulin and free fatty acids during longterm use of oral hypoglycaemic agents in diabetes mellitus. Brit. Med. J. iv, 25.Google Scholar
  12. Roth, J. 1971. Sulphonylureas: Effects in vivo and in vitro. Ann. Int. Med. 75, 607.Google Scholar
  13. Seltzer, H. S. 1972. A summary of criticisms of the findings and conclusions of the university Group Diabetes Program. Diabetes 21, 976.PubMedGoogle Scholar
  14. University Group Diabetes Program. 1970. A study of the effects of hypoglycaemic agents on vascular complications in patients with adult-onset diabetes. Diabetes 19, Supplement 2, 747.Google Scholar
  15. Wade, O. L., Hadden, D. R. and Hood, H. 1972. The prescribing of drugs used in the treatment of diabetes. Brit. J. Social and Preventive Med. In press.Google Scholar
  16. Weaver, J. A., Bhatia, S. K., Boyle, D., Hadden, D. R. and Montgomery, D. A. D. 1970. Cardiovascular state of newly discovered female diabetic subjects. Brit. Med. J. i, 783.CrossRefGoogle Scholar

Copyright information

© Springer 1973

Authors and Affiliations

  • D. R. Hadden
    • 1
  1. 1.Royal Victoria HospitalBelfast

Personalised recommendations